Evidence map›Paper›PMID 40457205›Full record

ArticleBMC bioinformatics2025

Universal multilayer network embedding reveals a causal link between GABA neurotransmitter and cancer.

Léo Pio-Lopez, Michael Levin

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Léo Pio-LopezAllen Discovery Center, Tufts University, Medford, USA.
Michael LevinAllen Discovery Center, Tufts University, Medford, USA. michael.levin@tufts.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe volume and complexity of biological data have significantly increased in recent years, often represented as network models continue to increase at a rapid pace. However, drug discovery in the context of complex phenotypes are hampered by the difficulties inherent in producing machine learning algorithms that can integrate molecular-genetic, biochemical, physiological, and other diverse datasets. Recent developments have expanded network analysis techniques, such as network embedding, to effectively explore multilayer network structures. Multilayer networks, which incorporate various nodes and connections in formats such as multiplex, heterogeneous, and bipartite networks, provide an effective framework for merging diverse and multi-scale biological data sources. However, current network embedding methods face challenges and limitations in addressing the heterogeneity and diversity of these networks. Therefore, there is an essential need for the development of new network embedding methods to manage the complexity and diversity of multi-omics biological information effectively.

resultsHere, we report a universal multilayer network embedding method MultiXVERSE, which is to the best of our knowledge the first one capable of handling any kind of multilayer network. We applied it to a molecular-drug-disease multiplex-heterogeneous network. Our model made new predictions about a link between GABA and cancer that we verified experimentally in the Xenopus laevis model.

conclusionsThe development of MultiXVERSE represents a significant advancement in the integration and analysis of multilayer networks for biological research. By providing a universal, scalable framework for multilayer network embedding, MultiXVERSE enables the systematic exploration of molecular and phenotypic interactions across diverse biological contexts. Our experimental validation of the predicted link between GABA and cancer using Xenopus laevis underscores its capability to generate biologically meaningful hypotheses and accelerate breakthroughs in multi-omics research. Future directions include applying MultiXVERSE to additional multi-omics datasets and integrating it with high-throughput experimental pipelines for systematic hypothesis generation and validation, particularly in drug discovery. Beyond its biological applications, MultiXVERSE is a versatile tool that can be utilized for analyzing multilayer networks in a wide range of fields, including social sciences and other complex systems. By offering a universal framework, MultiXVERSE paves the way for novel insights and interdisciplinary collaborations in multilayer network research.

Indexed as

Computational Biologygamma-Aminobutyric AcidNeoplasmsNeurotransmitter AgentsAlgorithmsAnimalsHumansMachine Learninggamma-Aminobutyric AcidNeurotransmitter AgentsAIcancerDrug discoveryDrug repositioningGABAMachine learningMulti-layer networkNetwork embedding

Identifiers

PMID40457205
PMCPMC12131449

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.